Scilex Holding Company

Healthcare · Drug Manufacturers - General · United States

Last price 1.85 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 13.01M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of ...